Almonds role in gut health underscored by new research
A clinical study published in November 2022 investigated how gut microbes break down almonds to produce butyrate, a specific microbiota product associated with several health benefits.
A team of researchers led by Professor Kevin Whelan from King’s College London set out to determine the impact whole and ground almonds have on the composition of gut microbiota, gut microbiota diversity and gut transit time.
Results of the four-week study showed that participants -- 75 healthy women and 12 health men with an average age of 27.5 years old – who consumed about two servings of almonds a day experienced small but significant differences in stool frequency as well as significant increases in butyrate in the colon. Researchers indicate that these findings suggest positive alterations to gut microbiota functionality. These results also confirm that almonds are well tolerated and did not lead to gastrointestinal symptoms, which indicates almond consumption may be a way to increase fiber without causing any adverse effects.
Dariela Roffe-Rackind, ABC’s director, Europe and global public relations, said the Almond Board’s public relations push last fall associated with the Whelan gut health study has proven popular with media around the world. So far this year, it is the top-performing study pitched by ABC to media and accounting for 32% of all ABC impressions focused on nutrition studies.
“To us, what this means is that the area of improving gut health through adding one whole food – almonds – really resonated with global media,” Roffe-Rackind said.
In July, following the study pitch, the Almond Board ran advertising on Meta (Facebook and Instagram) encouraging consumers to learn more about the gut health research.
The goal, Roffe-Rackind explained, is “to reach consumers, where they are and in more than one way, whether by reading an article in a trusted news source or seeing an ad as they scroll through their social feed.”
The ads appeared in the United States and were translated to run in eight other markets – India, Mexico, South Korea, Japan, Germany, Italy, France and the United Kingdom.